Assertio Holdings | DEPO - Operating Profit

Stock Price
11.72
Daily Change
-0.23 -1.92%
Monthly
-2.50%
Yearly
-0.07%
Q1 Forecast
11.30

Assertio Holdings reported $-3.05M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Cara Therapeutics USD -2.39M 3.49M Mar/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 5.59B 1.81B Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -34.34M 15.43M Sep/2024
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.65B 3.99B Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025